Ajani AE - Search Results

Year	Number of Results
1998	1
2000	1
2001	12
2002	17
2003	17
2004	9
2005	9
2006	7
2007	6
2008	10
2009	8
2010	9
2011	11
2012	3
2013	2
2014	3
2015	5
2016	4
2017	6
2018	6
2019	8
2020	10
2021	11
2022	6
2023	5
2024	1

1

Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.

Chow CK, Atkins ER, Hillis GS, Nelson MR, Reid CM, Schlaich MP, Hay P, Rogers K, Billot L, Burke M, Chalmers J, Neal B, Patel A, Usherwood T, Webster R, Rodgers A; QUARTET Investigators. Chow CK, et al. Lancet. 2021 Sep 18;398(10305):1043-1052. doi: 10.1016/S0140-6736(21)01922-X. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469767 Clinical Trial.

2

The mystery of coronary artery spasm.

Ajani AE, Yan BP. Ajani AE, et al. Heart Lung Circ. 2007 Feb;16(1):10-5. doi: 10.1016/j.hlc.2006.11.003. Epub 2006 Dec 28. Heart Lung Circ. 2007. PMID: 17196430 Review.

3

Contemporary revascularization strategies in 2002.

Ajani AE, Waksman R. Ajani AE, et al. Drugs Today (Barc). 2002 May;38(5):309-19. doi: 10.1358/dot.2002.38.5.677134. Drugs Today (Barc). 2002. PMID: 12532167 Review.

4

Bupropion and bradycardia.

Landau J, Ajani AE. Landau J, et al. Among authors: ajani ae. Med J Aust. 2008 Aug 4;189(3):180. doi: 10.5694/j.1326-5377.2008.tb01963.x. Med J Aust. 2008. PMID: 18673114 No abstract available.

5

Oral antiplatelet therapy and percutaneous coronary intervention.

Yan BP, Clark DJ, Ajani AE. Yan BP, et al. Among authors: ajani ae. Expert Opin Pharmacother. 2005 Jan;6(1):3-12. doi: 10.1517/14656566.6.1.3. Expert Opin Pharmacother. 2005. PMID: 15709878 Review.

6

Rivaroxaban in Stable Cardiovascular Disease.

Ajani AE. Ajani AE. N Engl J Med. 2018 Jan 25;378(4):395-6. doi: 10.1056/NEJMc1714934. N Engl J Med. 2018. PMID: 29372977 No abstract available.

7

Difference in a decade: percutaneous coronary interventions in Australia.

Dawson LP, Duffy SJ, Dinh D, Clark D, Brennan A, Ajani AE. Dawson LP, et al. Among authors: ajani ae. Intern Med J. 2021 Jan;51(1):138-139. doi: 10.1111/imj.15150. Intern Med J. 2021. PMID: 33572022 No abstract available.

8

Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.

Tan VP, Yan BP, Kiernan TJ, Ajani AE. Tan VP, et al. Among authors: ajani ae. Cardiovasc Revasc Med. 2009 Jan-Mar;10(1):36-44. doi: 10.1016/j.carrev.2008.11.001. Cardiovasc Revasc Med. 2009. PMID: 19159853 Review.

9

Drug-eluting stents for the treatment of in-stent restenosis: a clinical review.

Yan BP, Ajani AE, Waksman R. Yan BP, et al. Among authors: ajani ae. Cardiovasc Revasc Med. 2005 Jan-Mar;6(1):38-43. doi: 10.1016/j.carrev.2005.04.003. Cardiovasc Revasc Med. 2005. PMID: 16263355 Review.

10

Cost-Effectiveness of Transcatheter Aortic Valve Intervention (TAVI) Compared to Surgical Aortic Valve Replacement (SAVR) in Low- to Intermediate-Surgical-Risk Patients.

Azraai M, Gao L, Ajani AE. Azraai M, et al. Among authors: ajani ae. Cardiovasc Revasc Med. 2020 Sep;21(9):1164-1168. doi: 10.1016/j.carrev.2020.01.009. Epub 2020 Jan 15. Cardiovasc Revasc Med. 2020. PMID: 31980399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

164 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Results by year